When the weather warms up and the school year comes to an end, many of us add ordering a new swimsuit and buying sunscreen to the to-do list. One of my favorite summer chores is finding a new book to ...

MoonLake Immunotherapeutics shares surged 31% after the Financial Times reported, citing unnamed sources, that the company had rejected an initial acquisition offer by Merck & Co. for more than $3 ...

A key viral mechanism that allows HSV-1 to evade the brain’s natural defenses has been uncovered and tested to identify new ...

Future studies will investigate long-term implications of FMT on host metabolism and immune function, and effects on brain ...

In developing this automated cell therapy processing platform, Limula’s founders aim to create a disruptive production ...

The MIT model predicts molecular binding affinity at newfound speed and accuracy, offering a powerful tool for commercial drug discovery.

As difficult-to-treat infections continue to rise, phage therapies are becoming important complements to existing treatments.

Phase I trial patients experienced shrinkage of brain tumors and extended survival rates beyond the standard prognosis of one ...

Researchers still don’t fully understand the cause of multiple sclerosis or why the rate of progression is so difficult to ...

This technique could enable wearable devices to boost brain waste clearance in aging adults or patients with neurological ...

Sanofi to acquire Blueprint Medicines for up to $9.5B to expand its rare immunological disease portfolio, including an ...

Human study findings suggest there are subtypes within prediabetes, and that subtype could determine the foods individuals ...